about
Synlogic Inc is a biopharmaceutical company focuses on rare metabolic disorders, with a lead program in phenylketonuria (PKU) and homocystinuria (HCU). The company's pipeline includes therapeutics for enteric hyperoxaluria, gout, and cystinuria. Usin...
Read More
1.40
0.04
(2.94%)
27,231
XNAS Volume
XNAS 08 Aug, 2025 5:30 PM (EDT)
Not Eligible
Mid Valuation
Technically Neutral
Synlogic Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..